Aaron Brant
YOU?
Author Swipe
View article: (402) Peyronie's Disease Treatment- Active Vs. Stable Phase- Retrospective Review of Cases
(402) Peyronie's Disease Treatment- Active Vs. Stable Phase- Retrospective Review of Cases Open
Introduction Peyronie's disease (PD) may be treated with collagenase clostridium histolyticum (CCH) during the stable phase. However, the effectiveness and safety of this treatment during the active phase remain unclear. To address this, w…
View article: Antibiotic Use in Hospital Urinary Tract Infections After FDA Regulation
Antibiotic Use in Hospital Urinary Tract Infections After FDA Regulation Open
View article: Individual-level home values and cancer mortality in a statewide registry
Individual-level home values and cancer mortality in a statewide registry Open
Background Prior work assessing disparities in cancer outcomes has relied on regional socioeconomic metrics. These metrics average data across many individuals, resulting in a loss of granularity and confounding with other regional factors…
View article: VARIABILITY IN SELF-PAY PRICING FOR VASECTOMY AMONG UNITED STATES HOSPITALS
VARIABILITY IN SELF-PAY PRICING FOR VASECTOMY AMONG UNITED STATES HOSPITALS Open
View article: Trends over 20 years of antimicrobial prophylaxis for artificial urinary sphincter surgery
Trends over 20 years of antimicrobial prophylaxis for artificial urinary sphincter surgery Open
Introduction and Objective Perioperative antimicrobial prophylaxis is crucial for prevention of prosthesis and patient morbidity after artificial urinary sphincter (AUS) placement. While antibiotic guidelines exist for many urologic proced…
View article: (242) Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery: Trends after Publication of the AUA Best Practice Statement
(242) Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery: Trends after Publication of the AUA Best Practice Statement Open
Introduction In April 2008, the American Urological Association (AUA) released a Best Practice Statement on antimicrobial use in urologic surgery, in which the combination of an aminoglycoside with either vancomycin or a 1st/2nd generation…
View article: (543) Antibiotic Prophylaxis for Artificial Urinary Sphincter Surgery - Trends in AUA Best Practices Guideline Adherence
(543) Antibiotic Prophylaxis for Artificial Urinary Sphincter Surgery - Trends in AUA Best Practices Guideline Adherence Open
Introduction Infections involving an artificial urinary sphincter (AUS) can be devastating and costly. Antibiotic use during implantation is a mainstay in preserving the implant as well as reducing morbidity for patients. While antibiotic …
View article: (164) Real-World Practice in Peyronie’s Disease Management: Results from a National Survey of Urologists
(164) Real-World Practice in Peyronie’s Disease Management: Results from a National Survey of Urologists Open
Introduction There are many treatment options for men with Peyronie's disease, some which have been shown in randomized controlled trials to be more effective than placebo in reducing curvature and plaque size and others which do not have …
View article: The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer
The role of quantitative MRI-based prostate zonal parameters in predicting clinically significant prostate cancer Open
Introduction: We aimed to investigate the clinical utility of quantitative prostatic zonal measurements on in multiparametric magnetic resonance imaging (mpMRI) for the predication of clinically significant prostate cancer (csPCa). Methods…
View article: Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Supplementary Figure 1
View article: Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Supplementary Figure 2
View article: Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Purpose:To characterize immune cell expression among patients with non–muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG).Experimental Design:Patients with NMIBC treated with intravesical BCG (2008–2015) wer…
View article: Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Purpose:To characterize immune cell expression among patients with non–muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG).Experimental Design:Patients with NMIBC treated with intravesical BCG (2008–2015) wer…
View article: Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Supplementary Figure 2
View article: Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Supplementary Figure 1
View article: Real‐world practice in Peyronie's disease management: Results from a national survey of urologists
Real‐world practice in Peyronie's disease management: Results from a national survey of urologists Open
Background Despite many available treatments for Peyronie's disease (PD), practice patterns of available therapeutics are not well characterized. Objective We conducted a national survey of urologists to characterize real‐world practice pa…
View article: Findings from an international survey of urology trainee experience with prostate biopsy
Findings from an international survey of urology trainee experience with prostate biopsy Open
Objective To assess urology trainees' exposure to transperineal prostate biopsy (TP‐Bx) and intent to use TP‐Bx in practice. Subjects and Methods A 34‐question survey about prostate biopsy was distributed to urology trainees in the United …
View article: Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer Open
This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate can…
View article: Patterns in Transvaginal Mesh Surgery After Government Regulation in the United States
Patterns in Transvaginal Mesh Surgery After Government Regulation in the United States Open
This case series examines whether the rate of transvaginal mesh repair of pelvic organ prolapse changed after US Food and Drug Administration prohibitions on the sale and distribution of the mesh.
View article: Impact of MRI-Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-Analysis
Impact of MRI-Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-Analysis Open
View article: Embryonal rhabdomyosarcoma of the adult prostate: case report and review
Embryonal rhabdomyosarcoma of the adult prostate: case report and review Open
View article: PD30-06 RATES OF NEWLY DIAGNOSED ERECTILE DYSFUNCTION AFTER SURGERY FOR COLORECTAL CANCER
PD30-06 RATES OF NEWLY DIAGNOSED ERECTILE DYSFUNCTION AFTER SURGERY FOR COLORECTAL CANCER Open
You have accessJournal of UrologySexual Function/Dysfunction: Evaluation II (PD30)1 Sep 2021PD30-06 RATES OF NEWLY DIAGNOSED ERECTILE DYSFUNCTION AFTER SURGERY FOR COLORECTAL CANCER Christopher Gaffney, Nahid Punjani, Aaron Brant, Jonathan…
View article: Residual muscle-invasive disease at cystectomy is not accurately predicted by post-chemotherapy restaging protocols including DNA damage response gene mutation analysis
Residual muscle-invasive disease at cystectomy is not accurately predicted by post-chemotherapy restaging protocols including DNA damage response gene mutation analysis Open
View article: Upper Tract Urothelial Carcinoma in a Patient With Horseshoe Kidney
Upper Tract Urothelial Carcinoma in a Patient With Horseshoe Kidney Open
View article: PD42-01 RESIDUAL MUSCLE-INVASIVE DISEASE AT CYSTECTOMY IS NOT ACCURATELY PREDICTED BY POST-CHEMOTHERAPY RESTAGING PROTOCOLS INCLUDING DNA DAMAGE RESPONSE GENE MUTATION ANALYSIS
PD42-01 RESIDUAL MUSCLE-INVASIVE DISEASE AT CYSTECTOMY IS NOT ACCURATELY PREDICTED BY POST-CHEMOTHERAPY RESTAGING PROTOCOLS INCLUDING DNA DAMAGE RESPONSE GENE MUTATION ANALYSIS Open
You have accessJournal of UrologyBladder Cancer: Basic Research & Pathophysiology III (PD42)1 Apr 2020PD42-01 RESIDUAL MUSCLE-INVASIVE DISEASE AT CYSTECTOMY IS NOT ACCURATELY PREDICTED BY POST-CHEMOTHERAPY RESTAGING PROTOCOLS INCLUDING DNA…
View article: Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials Open
Purpose: To characterize immune cell expression among patients with non–muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG). Experimental Design: Patients with NMIBC treated with intravesical BCG (2008–2015) …
View article: MP78-10 INACCURACY OF CLINICAL STAGING AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
MP78-10 INACCURACY OF CLINICAL STAGING AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER Open
You have accessJournal of UrologyBladder Cancer: Invasive VI1 Apr 2018MP78-10 INACCURACY OF CLINICAL STAGING AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER Alexa Meyer, Aaron Brant, Paige Nichols, Max Kates, Adam Reese, …
View article: MP83-20 AN ASSESSMENT OF IMMUNE CHECKPOINT EXPRESSION AMONG PATIENTS WITH NMIBC UNDERGOING INTRAVESICAL BCG: IMPLICATIONS FOR ONGOING RANDOMIZED TRIALS.
MP83-20 AN ASSESSMENT OF IMMUNE CHECKPOINT EXPRESSION AMONG PATIENTS WITH NMIBC UNDERGOING INTRAVESICAL BCG: IMPLICATIONS FOR ONGOING RANDOMIZED TRIALS. Open
You have accessJournal of UrologyBladder Cancer: Non-invasive II1 Apr 2018MP83-20 AN ASSESSMENT OF IMMUNE CHECKPOINT EXPRESSION AMONG PATIENTS WITH NMIBC UNDERGOING INTRAVESICAL BCG: IMPLICATIONS FOR ONGOING RANDOMIZED TRIALS. Max Kates, A…
View article: Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma Open
Purpose Deleterious germline mutations contribute to pancreatic cancer susceptibility and are well documented in families in which multiple members have had pancreatic cancer. Methods To define the prevalence of these germline mutations in…
View article: High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer
High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer Open
Background: High dose-rate Intra-Operative Radiation Therapy (HD-IORT) is used to provide effective local control for patients with high-risk locally advanced or recurrent tumors. However, the utility of HD-IORT for patients with bladder c…